Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
New immunization study findings reported from University of Milan, Department of Public Health
December 31st, 2008
Fresh data on immunization are presented in the report 'The global impact of vaccination against hepatitis B: a historical overview.' According to recent research published in the journal Vaccine, "Hepatitis B virus (HBV) infection is a world wide public health problem of major concern. HBV infection may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma (HCC)." "Vaccination is the most effective measure to control and prevent hepatitis B and its long-term serious sequelae on global scale, both in terms of cost-effectiveness and benefit-cost ratios. According to the WHO recommendations, universal vaccination has been currently...
Source: Vaccine Weekly (2008-12-31)
|
